P2-253: Biweekly docetaxel and gemcitabine as first line chemotherapy in advanced non small cell lung cancer (NSCLC)

Autor:	José Luis Fírvida, Eva Perez, Margarita Amenedo, Jose Abal, M. Salgado, Jose Manuel Cervera, David Orts, Cristina Llorca, Gaspar Esquerdo, Manolo Ramos
Rok vydání:	2007
Předmět:	Oncology Pulmonary and Respiratory Medicine medicine.medical_specialty business.industry non-small cell lung cancer (NSCLC) medicine.disease Gemcitabine Docetaxel Internal medicine medicine First line chemotherapy business medicine.drug
Zdroj:	Journal of Thoracic Oncology. 2(8)
ISSN:	1556-0864
DOI:	10.1097/01.jto.0000283961.36710.5b
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcb9cd5322b162c245e0fea400daad14 Zobrazit plný text záznamu